Medication info
Tenelia M Extended-Release Tablets 10/750 mg

Tenelia M Extended-Release Tablets 10/750 mg

Prescription medicationTabletOral
Ingredient · strength
Metformin Hydrochloride›750mg / 1 tabletTeneligliptin Hydrobromide Hydrate›15.5mg / 1 tablet
Manufacturer / importer
HanDoc Co., Ltd.
Appearance
Yellow oval-shaped extended-release film-coated tablet
Packaging
30 tablets/bottle
Approval status
Active

MFDS item code 201501697 · Approved 2015.03.31 · Insurance code 652105470

Summary

Main use
Improvement of blood glucose control in patients with type 2 diabetes
Who takes it
Adults
Adult dose
The dose of this medicine should be determined based on each patient's current treatment regimen, efficacy, and tolerability. This medicine is generally administered once daily with the evening meal, and the dose should be adjusted gradually to reduce gastrointestinal adverse reactions associated with metformin. Take 1 tablet of this medicine 20/1000mg extended-release tablet once daily. Patients taking this medicine 10/750mg or 10/500mg extended-release tablets should take 2 tablets at the same time once daily. For patients who cannot achieve adequate glycemic control with metformin monotherapy, the initial dose of this medicine should provide a dose of teneligliptin 20 mg once daily and the patient's existing metformin dose. For patients switching from combination therapy with teneligliptin and metformin to this medicine, the dose of this medicine may be started at the existing doses of teneligliptin and metformin. When switching from immediate-release metformin to an extended-release formulation, glycemic control should be closely monitored and the dose adjusted appropriately. When administered concomitantly with a sulfonylurea, a reduction in the sulfonylurea dose may be considered to reduce the risk of hypoglycemia. The maximum recommended daily dose is teneligliptin 20mg and extended-release metformin 2000mg. The safety and efficacy of this medicine have not been specifically evaluated in patients switched to it from other glucose-lowering agents. Because changes may lead to alterations in glycemic control, any changes in the treatment of patients with type 2 diabetes should be made under careful monitoring. To maintain its extended-release properties, this medicine should be swallowed whole without splitting, crushing, grinding, or chewing.

Ingredients

Manufacturer
HanDoc Co., Ltd.

Efficacy & effects

Improvement of blood glucose control in patients with type 2 diabetes

View approved original text

This medication is used in conjunction with dietary adjustments and physical therapy to assist patients with type 2 diabetes in controlling their blood sugar levels. Teneligliptin and metformin work together to effectively lower blood sugar levels. It is used as a beneficial adjunct therapy for patients who find it challenging to control their blood sugar.

How to take

Adult dose

The dose of this medicine should be determined based on each patient's current treatment regimen, efficacy, and tolerability. This medicine is generally administered once daily with the evening meal, and the dose should be adjusted gradually to reduce gastrointestinal adverse reactions associated with metformin. Take 1 tablet of this medicine 20/1000mg extended-release tablet once daily. Patients taking this medicine 10/750mg or 10/500mg extended-release tablets should take 2 tablets at the same time once daily. For patients who cannot achieve adequate glycemic control with metformin monotherapy, the initial dose of this medicine should provide a dose of teneligliptin 20 mg once daily and the patient's existing metformin dose. For patients switching from combination therapy with teneligliptin and metformin to this medicine, the dose of this medicine may be started at the existing doses of teneligliptin and metformin. When switching from immediate-release metformin to an extended-release formulation, glycemic control should be closely monitored and the dose adjusted appropriately. When administered concomitantly with a sulfonylurea, a reduction in the sulfonylurea dose may be considered to reduce the risk of hypoglycemia. The maximum recommended daily dose is teneligliptin 20mg and extended-release metformin 2000mg. The safety and efficacy of this medicine have not been specifically evaluated in patients switched to it from other glucose-lowering agents. Because changes may lead to alterations in glycemic control, any changes in the treatment of patients with type 2 diabetes should be made under careful monitoring. To maintain its extended-release properties, this medicine should be swallowed whole without splitting, crushing, grinding, or chewing.

Precautions

This medication is used for the treatment of diabetes and helps in controlling blood sugar. However, caution must be exercised as rare side effects like severe lactic acidosis can occur with this medication. Patients with impaired kidney function, heart diseases, or liver dysfunction should not take this medication. Additionally, since this medication can cause hypoglycemia, special care should be taken when taken alongside insulin or other hypoglycemic agents. Patients about to undergo surgery or those scheduled for radiological contrast examinations should temporarily discontinue use of this medication and should restart only after confirming normal kidney function following the tests. Women who are pregnant or may become pregnant are advised against using this medication. This medication can occasionally cause gastrointestinal disturbances, dizziness, headaches, skin rashes, and if any unusual symptoms occur, consulting a physician is advised. Moreover, it may cause a decrease in vitamin B12 levels, thus regular blood tests for monitoring are important. It is also recommended to avoid alcohol while taking this medication, and if sudden vomiting, diarrhea, or dehydration occurs, consult a physician immediately. Elderly patients may have impaired kidney function and should regularly check kidney function before and during treatment. Finally, during the use of this medication, be well-informed about the symptoms of hypoglycemia and exercise caution when performing hazardous tasks such as driving or working at heights.

Side effects

  • Severe lactic acidosis
  • severe hypoglycemia
  • hypoglycemia
  • constipation
  • intestinal obstruction
  • hepatic dysfunction
  • interstitial pneumonia
  • bullous pemphigoid
  • acute pancreatitis
  • dizziness
Show 141 more
  • abdominal distension
  • abdominal discomfort
  • nausea
  • abdominal pain
  • bloating
  • stomatitis
  • gastric polyps
  • colon polyps
  • duodenal ulcers
  • gastroesophageal reflux disease
  • diarrhea
  • loss of appetite
  • increased amylase
  • increased lipase
  • elevated AST (GOT)
  • elevated ALT (GPT)
  • increased GGT
  • elevated ALP
  • proteinuria
  • ketonuria
  • potential hematuria
  • eczema
  • rash
  • itching
  • allergic dermatitis
  • arthralgia
  • elevated CK (CPK)
  • increased serum potassium concentration
  • fatigue
  • allergic rhinitis
  • elevated serum uric acid
  • peripheral edema
  • shingles
  • limb pain
  • upper abdominal pain
  • gastritis
  • upper respiratory infection
  • tremor
  • headache
  • weakness
  • hunger
  • fatigue
  • facial edema
  • indigestion
  • nausea
  • viral upper respiratory infection
  • rhinitis
  • cold sweats
  • diabetic retinopathy
  • vision decline
  • cough
  • pulmonary congestion
  • shortness of breath
  • drug overdose
  • benign prostatic hyperplasia
  • headache
  • diarrhea
  • chronic gastritis
  • irritable bowel syndrome
  • fatigue
  • cerebral infarction
  • hyperglycemia
  • cerebral infarction
  • hepatic coma
  • sensory disturbances
  • decreased sensation
  • tension headache
  • peripheral neuropathy
  • facial paralysis
  • sciatica
  • orthostatic dizziness
  • muscle weakness
  • back pain
  • lumbar spinal stenosis
  • tendonitis
  • cervical pain
  • bone pain
  • osteoarthritis
  • osteoporosis
  • muscle spasms
  • foot deformity
  • hypertrophic osteoarthropathy
  • bursitis
  • spinal osteoarthritis
  • intervertebral disc protrusion
  • intervertebral disc disorder
  • spinal ligament ossification
  • spinal foraminal stenosis
  • postmenopausal osteoporosis
  • rotator cuff syndrome
  • gastroenteritis
  • influenza
  • uterine pus formation
  • subcutaneous abscess
  • vomiting
  • abdominal pain
  • gastrointestinal motility disorders
  • decreased gastrointestinal motility
  • enteritis
  • toothache
  • anal rectal discomfort
  • acquired mixed hyperlipidemia
  • hypertriglyceridemia
  • vitamin D deficiency
  • abnormal weight gain
  • essential hypertension
  • orthostatic hypotension
  • white coat hypertension
  • bleeding
  • cough
  • insomnia
  • urticaria
  • otalgia
  • vertigo
  • iron deficiency anemia
  • food allergy
  • pressure ulcer
  • cataract
  • glaucoma
  • blurred vision
  • age-related macular degeneration
  • hyperthyroidism
  • hyperparathyroidism
  • coronary artery disease
  • unstable angina
  • angina
  • hearing loss
  • endolymphatic hydrops
  • benign prostatic hyperplasia
  • ovarian cyst
  • vulvar pruritus
  • menopausal symptoms
  • bile duct obstruction
  • toxic hepatitis
  • chronic cholecystitis
  • non-alcoholic fatty liver disease
  • alcoholic liver disease
  • eyelid damage
  • ligament sprain
  • lip injury
  • bruise

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly sealed container to prevent air and moisture exposure, and kept at room temperature between 1 and 30 degrees Celsius. Proper storage can maintain the drug's effectiveness over time.

Appearance and packaging

Appearance

Yellow oval-shaped extended-release film-coated tablet

Package unit

30 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.